Please wait

 

MAXIM GROUP LLC

300 Park Avenue

New York, New York 10022

 

July 31, 2025

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Re:Mainz Biomed N.V.

Registration Statement on Form F-1 (Registration No. 333-289095)

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, as placement agent in connection with the above referenced Registration Statement relating to the offer and issuance by the Registrant of certain of its securities, hereby joins the Registrant’s request that the effective date of the Registration Statement be accelerated so that it shall be declared effective at 8:00 AM Eastern Time on Monday, August 4, 2025, or as soon thereafter as practicable.

 

Pursuant to Rule 460 under the Act, we wish to advise you that the placement agent has distributed as many copies of the Preliminary Prospectus, dated July 30, 2025, to investors, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

 

This is to further advise you that the placement agent has and will continue to comply with Rule 15c2-8 of the Securities Exchange Act of 1934, as amended, with regard to the Preliminary Prospectus and any amended Prospectus.

 

If you require any additional information with respect to this letter, please contact Ali Panjwani of Pryor Cashman LLP at (212) 326-0820.

 

    Very truly yours,
     
    MAXIM GROUP LLC

 

  By: /s/ Ritesh M. Veera
  Name: Ritesh M. Veera
  Title: Co-Head of Investment Banking